Chemotherapy in bone and joint tuberculosis;Chemotherapie bei knochen- und gelenktuberkulose

Orthopade

Volumn 28, Issue 4, 1999, Pages 375-380

  Serke, M ^a   Hauer, B ^a   Loddenkemper, R ^a  

^a NONE

Author keywords

Bones and joints; Therapy; Tuberculosis extrapulmonary

Indexed keywords

ETHAMBUTOL; ISONIAZID; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ALLERGIC REACTION; COMBINATION CHEMOTHERAPY; DRUG CONTRAINDICATION; HUMAN; LIVER INJURY; LIVER TOXICITY; NEUROLOGIC DISEASE; REVIEW; SPINE INSTABILITY; TUBERCULOUS ARTHRITIS; TUBERCULOUS OSTEOMYELITIS;

ANTITUBERCULAR AGENTS; HUMANS; TUBERCULOSIS, OSTEOARTICULAR;

EID: 0032954127     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001320050360     Document Type: Review

References (27)

1. Albino JA, Reichman LB (1998) The treatment of tuberculosis. Respiration 65: 237-255
2. American Thoracic Society (1994) Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Res Crit Care Med 1359-1374
3. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR (1997) Noncompliance with directly observed therapy for tuberculosis. Chest 111: 1168-1173
4. Catena E, De Simone G, Caramon G, Ciaccia A (1997) Extrapulmonary tuberculosis. In: Wilson R (ed) Tuberculosis. European Respiratory Monograph. European Respiratory Society Journals Ltd, pp 175-194
5. Davidson PT, Fernandez E (1998) Bone and joint tuberculosis. In: Schlossberg D (ed) Tuberculosis, 2nd edn. Springer, Berlin Heidelberg New York
6. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK) (1995) Richtlinien zur Chemotherapie der Tuberkulose. Pneumologie 49: 217-225
7. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (D2K) (1997) 23. Informationsbericht. PMI Verlagsgruppe, Frankfurt a. M.
8. Gillespie SH, Kennedy N (1998) Fluoroquinolones: a new treatment for tuberculosis? Int J Tuberc Lung Dis 2: 265-271
9. Girling DJ, Darbyshire JH, Humphries MJ et al. (1988) Extra-pulmonary tuberculosis. Br Med Bull 44: 738-56
10. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR (1993) Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 328: 527-532
11. Grassi C, Peona V (1995) New drugs for tuberculosis. Eur Respir J 8 [Suppl 20]: 714-718
12. Hannachi MR, Martini M, Boulahbal H, Chaulet (1982) A comparison of three daily short-course regimens in osteo-articular tuberculosis in Algiers. Bull IUATLD 57: 46-47
13. Isemann MD (1993) Treatment of multidrugresistant tuberculosis. N Engl J Med 329: 784-791
14. Joint Tuberculosis Committee of the British Thoracic Society (1998) Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 53: 536-548
15. Kritzki AL, Rodrigues de Jesus LS, Andrade MK et al. (1997) Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes. Chest 111: 1162-1167
16. Loddenkemper R (1996) Tuberkulose. In: Stobbe H, Baumann G (Hrsg) Innere Medizin. Grundlagen und Klinik innerer Krankheiten, 7. Aufl. Ullstein, Mosby Berlin Wiesbaden
17. Magdorf K, Ertel M, Wahn U (1997) Tuberkulose im Kindesalter. 2. Tuberkuloseformen, Symptomatik und Therapie. Pädiat Prax 52: 299-309
18. Matthiessen W, Loddenkemper R (1987) Tuberkulose - Grundlagen einer rationalen Therapie. Intern. Welt 6: 150-159
19. Medical Research Council Working Party on Tuberculosis of the Spine (1986) A controlled trial of 6-months and 9-month regimens of chemotherapy in patients undergoing radical surgery for tuberculosis of the spine in Hong Kong. Tubercle 67: 243-259
20. Pabloz-Mendez A, Raviglione MC, Laszlo A et al. (1988) For the WHO-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculisis Drug Resistance surveillance. N Engl J Med 338: 1641-1649
21. Rezai AR, Lee M, Cooper PR (1996) Pott's disease. In: Rom WN, Garay S (eds) Tuberculosis. Little, Brown & Company, Boston, pp 623-33
22. Schaberg T, Gloger G, Reichert G, Mauch H, Lode H (1995) Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993. Eur Respir J 8: 278-284
23. Schaberg T, Rebhand K, Lode H (1996) Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 9: 2026-2030
24. Thornpson NP, Caplin ME, Hamilton MI, Gillespie SH, Clarke SW, Burroughs AK, McIntyre (1995) Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J 8: 1384-1388
25. Weinberger SE (1993) Recent advances in pulmonary medicine. N Engl J Med 328: 1462-1470
26. WHO (1997) Guidelines for the management of drug-resistant tuberculosis. WHO/TB96: 210 (Rev.1)
27. WHO (1997) Treatment of tuberculosis: Guidelines for national programmes, 2nd edn. WHO/TB/97: 220